Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-25 @ 3:20 AM
NCT ID:
NCT03394105
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 20, and NSCLC patients with malignant pleural effusion and related symptoms
* ECOG ≤ 2
* Blood test ANC≥ 1500/mm3, Hb ≥ 8.0g/dl, platelet count ≥ 100000/mm3 Serum creatinine ≤ 1.8mg/dl, Total bilirubin within normal limits, Transaminases ≤ 1.5 x UNL, Alkaline phosphatase ≤ 2.5 X UNL BUN ≤ 25mg/dl, Creatinine clearance ≥ 50ml/min
* Negative serum or urine pregnancy test for women for childbearing age
* Patients who provide written informed consent for the study
Exclusion Criteria:
* Age \< 20
* Patients who were previously perfomed pleurodesis
* Patients who were previously treated with thoracic radiosurgery
* Patinet with bilateral pleural effusion
* Age ≥ 80yrs
* Patients with histories of hypersensitivity to Docetaxel
* Patients with cardiovascular, respiratory, hepatic, renal, gastrointestinal, neunological disease, asthma, MI, stroke, arrhythmia, uncontrolled hypertionsion, etc. that would effect absorption, distribution, and metabolism of IP or be risk factors during IP administrion.
* Patients who could not understand the study procedure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
79 Years
Study:
NCT03394105
Study Brief:
Protocol Section:
NCT03394105